Epcoritamab for Relapsed/Refractory EBV+ Post‐Transplant Lymphoproliferative Disorder of DLBCL‐Type

Abstract Background Patients with relapsed/refractory post‐transplant lymphoproliferative disorder (R/R PTLD) following solid‐organ transplants (SOT) or hematopoietic stem cell transplants (HSCT) after frontline chemoimmunotherapy have dismal outcomes. There is no standard of care for this group of...

Descripción completa

Detalles Bibliográficos

Autores principales:	Li Yuan Chan, Simon O'Connor, Dima El‐Sharkawi, Sunil Iyengar
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2025-12-01
Colección:	eJHaem
Materias:	bispecific antibodies diffuse large b‐cell lymphoma EBV post‐transplant lymphoproliferative disorders
Acceso en línea:	https://doi.org/10.1002/jha2.70156
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!